Encompass Health Corp Quarterly Operating Income (Loss) in USD from Q1 2015 to Q4 2022

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
Encompass Health Corp quarterly/annual Operating Income (Loss) history and growth rate from Q1 2015 to Q4 2022.
  • Encompass Health Corp Operating Income (Loss) for the quarter ending December 31, 2022 was $152M, a 18.3% increase year-over-year.
  • Encompass Health Corp Operating Income (Loss) for the twelve months ending December 31, 2022 was $540M, a 3.59% decline year-over-year.
  • Encompass Health Corp annual Operating Income (Loss) for 2022 was $540M, a 3.59% decline from 2021.
  • Encompass Health Corp annual Operating Income (Loss) for 2021 was $560M, a 0.76% decline from 2020.
  • Encompass Health Corp annual Operating Income (Loss) for 2020 was $564M, a 7.88% decline from 2019.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Quarterly (USD)
Operating Income (Loss), YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q4 2022 $540M $152M +$23.5M +18.3% Oct 1, 2022 Dec 31, 2022 10-K 2023-02-27
Q3 2022 $516M $128M -$13.9M -9.83% Jul 1, 2022 Sep 30, 2022 10-K 2023-02-27
Q2 2022 $530M $129M -$18.2M -12.4% Apr 1, 2022 Jun 30, 2022 10-K 2023-02-27
Q1 2022 $548M $132M -$11.5M -8.04% Jan 1, 2022 Mar 31, 2022 10-K 2023-02-27
Q4 2021 $560M $128M -$39.9M -23.7% Oct 1, 2021 Dec 31, 2021 10-K 2023-02-27
Q3 2021 $600M $141M -$9.7M -6.42% Jul 1, 2021 Sep 30, 2021 10-K 2023-02-27
Q2 2021 $609M $147M +$61.6M +72.3% Apr 1, 2021 Jun 30, 2021 10-K 2023-02-27
Q1 2021 $548M $143M -$16.3M -10.2% Jan 1, 2021 Mar 31, 2021 10-K 2023-02-27
Q4 2020 $564M $168M +$27.1M +19.2% Oct 1, 2020 Dec 31, 2020 10-K 2021-02-26
Q3 2020 $537M $151M -$100K -0.07% Jul 1, 2020 Sep 30, 2020 10-K 2021-02-26
Q2 2020 $537M $85.2M -$67.4M -44.2% Apr 1, 2020 Jun 30, 2020 10-K 2021-02-26
Q1 2020 $604M $159M -$7.8M -4.67% Jan 1, 2020 Mar 31, 2020 10-K 2021-02-26
Q4 2019 $612M $141M +$47.8M +51.2% Oct 1, 2019 Dec 31, 2019 10-K 2021-02-26
Q3 2019 $564M $151M -$3.3M -2.14% Jul 1, 2019 Sep 30, 2019 10-K 2021-02-26
Q2 2019 $568M $153M -$4.7M -2.99% Apr 1, 2019 Jun 30, 2019 10-K 2021-02-26
Q1 2019 $572M $167M +$17.1M +11.4% Jan 1, 2019 Mar 31, 2019 10-K 2021-02-26
Q4 2018 $555M $93.4M -$51.3M -35.5% Oct 1, 2018 Dec 31, 2018 10-K 2020-02-27
Q3 2018 $607M $155M +$9.3M +6.41% Jul 1, 2018 Sep 30, 2018 10-K 2020-02-27
Q2 2018 $597M $157M +$16M +11.3% Apr 1, 2018 Jun 30, 2018 10-K 2020-02-27
Q1 2018 $581M $150M +$2.9M +1.97% Jan 1, 2018 Mar 31, 2018 10-K 2020-02-27
Q4 2017 $578M $145M -$800K -0.55% Oct 1, 2017 Dec 31, 2017 10-K 2019-02-27
Q3 2017 $579M $145M -$3M -2.02% Jul 1, 2017 Sep 30, 2017 10-K 2019-02-27
Q2 2017 $582M $141M -$8.9M -5.93% Apr 1, 2017 Jun 30, 2017 10-K 2019-02-27
Q1 2017 $591M $147M +$2.9M +2.01% Jan 1, 2017 Mar 31, 2017 10-K 2019-02-27
Q4 2016 $588M $146M +$10M +7.38% Oct 1, 2016 Dec 31, 2016 10-K 2018-02-28
Q3 2016 $578M $148M +$27M +22.3% Jul 1, 2016 Sep 30, 2016 10-K 2018-02-28
Q2 2016 $551M $150M +$26.8M +21.7% Apr 1, 2016 Jun 30, 2016 10-K 2018-02-28
Q1 2016 $524M $144M +$38.6M +36.6% Jan 1, 2016 Mar 31, 2016 10-K 2018-02-28
Q4 2015 $486M $136M Oct 1, 2015 Dec 31, 2015 8-K 2017-09-19
Q3 2015 $121M Jul 1, 2015 Sep 30, 2015 8-K 2017-09-19
Q2 2015 $123M Apr 1, 2015 Jun 30, 2015 8-K 2017-09-19
Q1 2015 $106M Jan 1, 2015 Mar 31, 2015 8-K 2017-09-19
* An asterisk sign (*) next to the value indicates that the value is likely invalid.